Key Takeaways:
- Thermo Fisher Scientific (TMO, Financial) is expected to release earnings on April 23, with projected EPS of $5.10.
- Analysts predict a 1.2% decline in revenue year-over-year, with expectations set at $10.23 billion.
- The company holds an "Outperform" recommendation with a significant upside potential based on target price estimates.
Overview of Thermo Fisher's Upcoming Earnings Release
Thermo Fisher Scientific (NYSE: TMO) is gearing up to announce its first-quarter earnings before the market opens on April 23. Analysts are expecting an earnings per share (EPS) of $5.10, representing a slight year-over-year decrease of 0.2%. Revenue is anticipated to reach $10.23 billion, marking a 1.2% dip from the previous year. While the company has consistently surpassed EPS expectations 75% of the time over the past two years, the past three months have shown no upward revisions, with forecasts experiencing 17 downward adjustments for EPS and 13 for revenue.
Wall Street Analysts' Forecasts
Analysts from 28 firms have provided one-year price targets for Thermo Fisher Scientific Inc (TMO, Financial), with an average target of $626.61. This target suggests a potential upside of 45.09% from the current trading price of $431.87. Estimates range from a high of $767.00 to a low of $475.00. For more comprehensive estimate data, investors can visit the Thermo Fisher Scientific Inc (TMO) Forecast page.
The consensus recommendation from 33 brokerage firms gives Thermo Fisher Scientific Inc (TMO, Financial) an average brokerage recommendation of 1.9, which corresponds to an "Outperform" rating. This rating is derived from a scale of 1 to 5, where 1 indicates a Strong Buy and 5 suggests a Sell.
GF Value and Fair Valuation Insights
According to GuruFocus' proprietary estimates, the GF Value for Thermo Fisher Scientific Inc (TMO, Financial) in one year is projected at $586.30. This valuation suggests an upside potential of 35.76% from the current price of $431.87. The GF Value is calculated by considering historical trading multiples, past business growth, and future performance expectations. For detailed valuation data, investors are encouraged to explore the Thermo Fisher Scientific Inc (TMO) Summary page.
